![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Completes $60 Million Note Offering Secured by Argatroban Royalties
February 06, 2007 16:05 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Feb. 6, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that its newly formed, wholly-owned subsidiary has closed a private placement of $60 million in...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Announces Presentation/Webcast At BIO CEO Conference
February 05, 2007 16:35 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Feb. 5, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it will participate in the 9th Annual BIO CEO & Investor Conference, taking place February...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Announces Conference Call to Discuss Fourth Quarter and Year End 2006 Results
January 30, 2007 08:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Jan. 30, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) will hold an investor conference call on Friday, March 9, 2007 at 8:00 a.m. ET to discuss its fourth quarter and year...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Announces Presentation/Webcast At 25th Annual JPMorgan Healthcare Conference
January 04, 2007 08:00 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Jan. 4, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it will participate in the 25th Annual JPMorgan Healthcare Conference, taking place January 8-11,...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
FDA Accepts Encysive's Complete Response to THELIN New Drug Application
December 28, 2006 13:53 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 28, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's complete...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Announces Launch of Thelin in Germany
December 18, 2006 02:30 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 18, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets are now commercially available in Germany for...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals' THELIN (sitaxentan sodium) Receives Positive Opinion From Australian Health Authority
December 15, 2006 13:47 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 15, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that the Australian Drug Evaluation Committee (ADEC) of the Therapeutic Goods Administration (TGA)...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Submits Response to FDA For Thelin New Drug Application
December 14, 2006 21:03 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 14, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced it has provided the information requested by the U.S. Food and Drug Administration (FDA) in its letter...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Expects to Submit Revised Response to Thelin Approvable Letter Within Several Days
December 14, 2006 08:35 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 14, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) announced today that the U.S. Food and Drug Administration (FDA) informed the Company that its response to the...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Receives FDA Clearance to Resume Clinical Studies With TBC3711
December 07, 2006 18:45 ET
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 7, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to initiate and resume...